Form D · Biotechnology
Aliva Biopharmaceuticals, LLC
Pasadena, CA · CIK 0001480832
Offering snapshot reported Jan 13, 2010 · SEC filing
- Reported sold
- $12.9M Offering amount: $12.9M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 30, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2010 | Initial | $12,870,407 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-137773
Class A Common Shares; Series A-1 and A-2 Preferred Shares
Source: Form D, filed Jan 13, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Larry Green | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
670 N. Rosemead Blvd. Suite 201
Pasadena, CA, 91107
Pasadena, CA, 91107